Weigao Blood: Net profit of 220 million yuan in the first half of 2025, a year-on-year increase of 10.11%

Weigao Blood announced that in the first half of 2025, operating revenue was 1.765 billion yuan, a year-on-year increase of 8.52%. Net profit was 220 million yuan, a year-on-year increase of 10.11%. The company plans to distribute a cash dividend of 1.6 yuan for every 10 shares to all shareholders, totaling a cash dividend of 65.8231 million yuan, accounting for 29.89% of the net profit attributable to shareholders of the listed company in the consolidated financial statements